<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05005611</url>
  </required_header>
  <id_info>
    <org_study_id>XPRPG8L0021~22</org_study_id>
    <nct_id>NCT05005611</nct_id>
  </id_info>
  <brief_title>Probiotics Regulates Skin Care in Children</brief_title>
  <official_title>Probiotics Regulates Skin Care in Children : A Randomized, Double-blind Clinical Trial With Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glac Biotech Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics, a component that is generally referred to as a living microorganism or a&#xD;
      microorganism present in a host. Most studies have shown that probiotics can regulate immune&#xD;
      function in the body. Many studies have attempted to understand whether the use of probiotics&#xD;
      can prevent allergic diseases or not.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 31, 2021</start_date>
  <completion_date type="Anticipated">October 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Skin Care in children.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blind.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Skin severity scoring</measure>
    <time_frame>3 months</time_frame>
    <description>According to the scale to estimate skin severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood analysis</measure>
    <time_frame>3 months</time_frame>
    <description>ELISA analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NGS in gastrointestinal tract</measure>
    <time_frame>3 months</time_frame>
    <description>The difference of NGS ( Next Generation Sequence ) in gastrointestinal tract between 0 month and the 3rd month.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life quality</measure>
    <time_frame>3 months</time_frame>
    <description>The questionnaire of life quality in three months.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Skin Care</condition>
  <condition>Probiotics</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotics-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotics-2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotics-3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A pack of powder without probiotics.&#xD;
1 pack / day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics-1</intervention_name>
    <description>A pack of powder with probiotics-1&#xD;
1 pack / day</description>
    <arm_group_label>Probiotics-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics-2</intervention_name>
    <description>A pack of powder with probiotics-2&#xD;
1 pack / day</description>
    <arm_group_label>Probiotics-2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics-3</intervention_name>
    <description>A pack of powder with probiotics-3&#xD;
1 pack / day</description>
    <arm_group_label>Probiotics-3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Estimated by PI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Be allergic to medicine&#xD;
&#xD;
          -  Take medicine like immune inhibition, or steroid injection in two weeks&#xD;
&#xD;
          -  Participate in another clinical research or immune therapy in one month&#xD;
&#xD;
          -  Have severe disease&#xD;
&#xD;
          -  Inappropriate for this trial judged by PI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kuo Ho-Chang</last_name>
    <phone>(07)7317123</phone>
    <phone_ext>8320</phone_ext>
    <email>erickuo48@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung City</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ho-Chang Kuo, MD, PhD</last_name>
      <phone>+886-7-7317123</phone>
      <phone_ext>8320</phone_ext>
      <email>erickuo48@yahoo.com.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chang Gung Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Ho-Chang Kuo</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

